Soriano V - Search Results

1

HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.

de Mendoza C, Anta L, García F, Pérez-Elías MJ, Gutiérrez F, Llibre JM, Menéndez-Arias L, Dalmau D, Soriano V. de Mendoza C, et al. Among authors: soriano v. AIDS Rev. 2009 Jan-Mar;11(1):39-51. AIDS Rev. 2009. PMID: 19290033

2

Mechanisms of resistance to antiretroviral drugs--clinical implications.

de Mendoza C, Gallego O, Soriano V. de Mendoza C, et al. Among authors: soriano v. AIDS Rev. 2002 Apr-Jun;4(2):64-82. AIDS Rev. 2002. PMID: 12152520 Review.

3

Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database.

Poveda E, Anta L, Blanco JL, Pérez-Elías MJ, García F, Leal M, Ribera E, Gutiérrez F, Soriano V, de Mendoza C; Resistance Platform of the Spanish AIDS Research Network (ResRIS). Poveda E, et al. Among authors: soriano v. AIDS. 2010 Jan 28;24(3):469-71. doi: 10.1097/QAD.0b013e328331a4b8. AIDS. 2010. PMID: 20057310

4

Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.

Soriano V, de Mendoza C. Soriano V, et al. HIV Clin Trials. 2002 May-Jun;3(3):249-57. doi: 10.1310/hct.2002.3.3.009. HIV Clin Trials. 2002. PMID: 12032884 Review.

5

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.

de Mendoza C, del Romero J, Rodríguez C, Corral A, Soriano V. de Mendoza C, et al. Among authors: soriano v. AIDS. 2002 Sep 6;16(13):1830-2. doi: 10.1097/00002030-200209060-00019. AIDS. 2002. PMID: 12218398

6

Resistance to HIV protease inhibitors: mechanisms and clinical consequences.

de Mendoza C, Soriano V. de Mendoza C, et al. Among authors: soriano v. Curr Drug Metab. 2004 Aug;5(4):321-8. doi: 10.2174/1389200043335522. Curr Drug Metab. 2004. PMID: 15320704 Review.

7

Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?

de Mendoza C, Sanchez-Conde M, Ribera E, Domingo P, Soriano V. de Mendoza C, et al. Among authors: soriano v. AIDS Rev. 2004 Jul-Sep;6(3):169-80. AIDS Rev. 2004. PMID: 15595434 Review.

8

Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.

Martín-Carbonero L, Gil P, García-Benayas T, Barreiro P, Blanco F, de Mendoza C, Maida I, González-Lahoz J, Soriano V. Martín-Carbonero L, et al. Among authors: soriano v. AIDS Res Hum Retroviruses. 2006 Dec;22(12):1231-5. doi: 10.1089/aid.2006.22.1231. AIDS Res Hum Retroviruses. 2006. PMID: 17209764

9

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients.

de Mendoza C, Morelló J, Garcia-Gascó P, Rodríguez-Novoa S, Soriano V. de Mendoza C, et al. Among authors: soriano v. Expert Opin Pharmacother. 2007 Apr;8(6):839-50. doi: 10.1517/14656566.8.6.839. Expert Opin Pharmacother. 2007. PMID: 17425479

10

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.

de Mendoza C, Jiménez-Nacher I, Garrido C, Barreiro P, Poveda E, Corral A, Zahonero N, González-Lahoz J, Soriano V. de Mendoza C, et al. Among authors: soriano v. Clin Infect Dis. 2008 Jun 1;46(11):1782-5. doi: 10.1086/588045. Clin Infect Dis. 2008. PMID: 18426370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,490 results

Search Page

Filters